Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF).

Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2 ...

Olivia Culpo's fur coat stole the spotlight even before the first hard hit landed at Lincoln Financial Field on January 11.

This small-cap industrial is quietly working through a transition of its own. A tighter focus on margins, a gradual shift ...

This means that early diagnostic tests, particularly in the first 42 hours after a baby is born, can detect many health conditions before the damage begins. It also supports the baby's long-term ...

Even before diving into advanced features, you can open your streaming app of choice, Zoom, Google Meet, etc., and select the ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Tuesday affirmed a district court decision finding that ...

Amtech Systems Inc (NASDAQ:ASYS) is one of the best performing micro cap stocks in 2025. On December 11, Benchmark reaffirmed ...

Radar-based sensors seem to be having a moment at CES, especially in tech meant for people to keep tabs on their aging family ...

Researchers are shifting focus from large arteries to microvessels, where nitric oxide activity may signal early circulatory ...

The Bills have a lengthy injury report ahead of a road playoff game where they’re currently a 1.5-point favorite. McDermott ...

Garmin fitness watches are full of powerful and sometimes well-hidden features. Here are 10 things you can customize, enable, ...